2-(MORPHOLIN-4-YL)-L,7-NAPHTHYRIDINES
The present invention relates to substituted 2-(morpholin-4-yl)-l,7-naphthyridine compounds of general formula (I) or (lb), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds...
Saved in:
Main Authors | , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
27.04.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to substituted 2-(morpholin-4-yl)-l,7-naphthyridine compounds of general formula (I) or (lb), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.
Compuestos 2-(morfolin-4-iI)-1,7-naftiridina sustituidos de la fórmula general (I) o (Ib), (ver Fórmulas) métodos de preparación de dichos compuestos, compuestos intermediarios de utilidad para preparar dichos compuestos, composiciones farmacéuticas y combinaciones que comprenden dichos compuestos y el uso de dichos compuestos en la elaboración de una composición farmacéutica para el tratamiento o la profilaxis de una enfermedad, en particular de una enfermedad hiperproliferativa como único agente o en combinación con otros ingredientes activos. |
---|---|
Bibliography: | Application Number: MX20170001637 |